Burlington Stores, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Burlington Stores, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $11.57B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $10.63B | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $9.73B | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $8.70B | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | $9.32B | Mar 15, 2024 |
| FY2022 | Jan 30, 2021 | $5.76B | Mar 13, 2023 |
| FY2021 | Feb 1, 2020 | $7.29B | Mar 16, 2022 |
| FY2020 | Feb 2, 2019 | $6.67B | Mar 15, 2021 |
| FY2019 | Feb 3, 2018 | $6.11B | Mar 13, 2020 |
| FY2018 | Jan 28, 2017 | $5.59B | Mar 20, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $11.55B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $10.62B | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $9.71B | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $8.68B | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | $9.31B | Mar 15, 2024 |
| FY2020 | Jan 30, 2021 | $2.28B | Mar 15, 2021 |
| FY2020 | Oct 31, 2020 | $1.66B | Mar 15, 2021 |
| FY2020 | Aug 1, 2020 | $1.01B | Mar 15, 2021 |
| FY2020 | May 2, 2020 | $798.00M | Mar 15, 2021 |
| FY2020 | Feb 1, 2020 | $2.20B | Mar 15, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Jan 31, 2015 | $1.49B | Mar 25, 2015 |
| FY2014 | Nov 1, 2014 | $1.16B | Mar 25, 2015 |
| FY2014 | Aug 2, 2014 | $1.04B | Mar 25, 2015 |
| FY2014 | May 3, 2014 | $1.13B | Mar 25, 2015 |
| FY2014 | Feb 1, 2014 | $1.33B | Mar 25, 2015 |
| FY2014 | Nov 2, 2013 | $1.06B | Mar 25, 2015 |
| FY2014 | Aug 3, 2013 | $963.71M | Mar 25, 2015 |
| FY2014 | May 4, 2013 | $1.07B | Mar 25, 2015 |
| FY2013 | Feb 2, 2013 | $1.32B | Mar 31, 2014 |
| FY2013 | Oct 27, 2012 | $967.89M | Mar 31, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 30, 2021 | $969.49M | Mar 15, 2021 |
| FY2020 | Oct 31, 2020 | $748.88M | Mar 15, 2021 |
| FY2020 | Aug 1, 2020 | $462.33M | Mar 15, 2021 |
| FY2020 | May 2, 2020 | $15.81M | Mar 15, 2021 |
| FY2020 | Feb 1, 2020 | $927.30M | Mar 15, 2021 |
| FY2020 | Nov 2, 2019 | $752.04M | Mar 15, 2021 |
| FY2020 | Aug 3, 2019 | $685.94M | Mar 15, 2021 |
| FY2020 | May 4, 2019 | $667.23M | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | $835.53M | Mar 13, 2020 |
| FY2019 | Nov 3, 2018 | $692.48M | Mar 13, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $610.15M | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $503.64M | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $339.65M | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $230.12M | Mar 17, 2025 |
| FY2024 | Jan 29, 2022 | $230.12M | Mar 17, 2025 |
| FY2020 | Jan 30, 2021 | $155.99M | Mar 15, 2021 |
| FY2020 | Oct 31, 2020 | $8.02M | Mar 15, 2021 |
| FY2020 | Aug 1, 2020 | ($46.78M) | Mar 15, 2021 |
| FY2020 | May 2, 2020 | ($333.73M) | Mar 15, 2021 |
| FY2020 | Feb 1, 2020 | $206.33M | Mar 15, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.82B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $3.55B | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $3.29B | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $2.88B | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | $2.87B | Mar 15, 2024 |
| FY2022 | Jan 30, 2021 | $2.33B | Mar 13, 2023 |
| FY2021 | Feb 1, 2020 | $2.23B | Mar 16, 2022 |
| FY2020 | Feb 2, 2019 | $2.02B | Mar 15, 2021 |
| FY2019 | Feb 3, 2018 | $1.86B | Mar 13, 2020 |
| FY2018 | Jan 28, 2017 | $1.72B | Mar 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.23B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $863.38M | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $868.74M | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $596.39M | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | $833.16M | Mar 15, 2024 |
| FY2022 | Jan 30, 2021 | $219.18M | Mar 13, 2023 |
| FY2021 | Feb 1, 2020 | $891.73M | Mar 16, 2022 |
| FY2020 | Feb 2, 2019 | $639.65M | Mar 15, 2021 |
| FY2019 | Feb 3, 2018 | $607.25M | Mar 13, 2020 |
| FY2018 | Jan 28, 2017 | $615.92M | Mar 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.06B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $880.38M | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $492.64M | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | $447.39M | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | $352.47M | Mar 15, 2024 |
| FY2022 | Jan 30, 2021 | $273.28M | Mar 13, 2023 |
| FY2021 | Feb 1, 2020 | $328.36M | Mar 16, 2022 |
| FY2020 | Feb 2, 2019 | $295.77M | Mar 15, 2021 |
| FY2019 | Feb 3, 2018 | $268.19M | Mar 13, 2020 |
| FY2018 | Jan 28, 2017 | $187.51M | Mar 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $9.92B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $8.77B | Mar 19, 2026 |
| FY2024 | Feb 3, 2024 | $7.71B | Mar 17, 2025 |
| FY2023 | Jan 28, 2023 | $7.27B | Mar 15, 2024 |
| FY2022 | Jan 29, 2022 | $7.09B | Mar 13, 2023 |
| FY2021 | Jan 30, 2021 | $6.78B | Mar 16, 2022 |
| FY2020 | Feb 1, 2020 | $5.59B | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | $3.08B | Mar 13, 2020 |
| FY2018 | Feb 3, 2018 | $2.81B | Mar 20, 2019 |
| FY2017 | Jan 28, 2017 | $2.57B | Mar 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.81B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $1.37B | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | $996.93M | Mar 19, 2026 |
| FY2025 | Jan 28, 2023 | $794.91M | Mar 19, 2026 |
| FY2024 | Jan 29, 2022 | $760.42M | Mar 17, 2025 |
| FY2023 | Jan 30, 2021 | $464.75M | Mar 15, 2024 |
| FY2022 | Feb 1, 2020 | $528.15M | Mar 13, 2023 |
| FY2021 | Feb 2, 2019 | $322.71M | Mar 16, 2022 |
| FY2020 | Feb 3, 2018 | $86.77M | Mar 15, 2021 |
| FY2019 | Jan 28, 2017 | ($49.81M) | Mar 13, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $47.06M | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $47.06M | Mar 19, 2026 |
| FY2024 | Feb 3, 2024 | $47.06M | Mar 17, 2025 |
| FY2023 | Jan 28, 2023 | $47.06M | Mar 15, 2024 |
| FY2022 | Jan 29, 2022 | $47.06M | Mar 13, 2023 |
| FY2021 | Jan 30, 2021 | $47.06M | Mar 16, 2022 |
| FY2020 | Feb 1, 2020 | $47.06M | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | $47.06M | Mar 13, 2020 |
| FY2018 | Feb 3, 2018 | $47.06M | Mar 20, 2019 |
| FY2017 | Jan 28, 2017 | $47.06M | Mar 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.10B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $1.49B | Mar 19, 2026 |
| FY2024 | Feb 3, 2024 | $984.06M | Mar 17, 2025 |
| FY2023 | Jan 28, 2023 | $644.42M | Mar 15, 2024 |
| FY2022 | Jan 29, 2022 | $414.29M | Mar 13, 2023 |
| FY2021 | Jan 30, 2021 | ($11.70M) | Mar 16, 2022 |
| FY2020 | Feb 1, 2020 | $204.80M | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | ($260.92M) | Mar 13, 2020 |
| FY2018 | Feb 3, 2018 | ($675.66M) | Mar 20, 2019 |
| FY2017 | Jan 28, 2017 | ($1.06B) | Mar 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.23B | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | $994.70M | Mar 19, 2026 |
| FY2024 | Feb 3, 2024 | $925.36M | Mar 17, 2025 |
| FY2023 | Jan 28, 2023 | $872.62M | Mar 15, 2024 |
| FY2022 | Jan 29, 2022 | $1.09B | Mar 13, 2023 |
| FY2021 | Jan 30, 2021 | $1.38B | Mar 16, 2022 |
| FY2020 | Feb 1, 2020 | $403.07M | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | $112.27M | Mar 13, 2020 |
| FY2018 | Feb 3, 2018 | $133.29M | Mar 20, 2019 |
| FY2017 | Jan 28, 2017 | $81.60M | Mar 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.03B | Mar 19, 2026 |
| FY2024 | Feb 1, 2025 | $1.70B | Mar 17, 2025 |
| FY2023 | Feb 3, 2024 | $1.39B | Mar 15, 2024 |
| FY2022 | Jan 28, 2023 | $1.49B | Mar 13, 2023 |
| FY2021 | Jan 29, 2022 | $1.53B | Mar 16, 2022 |
| FY2020 | Jan 30, 2021 | $2.07B | Mar 15, 2021 |
| FY2019 | Feb 1, 2020 | $961.42M | Mar 13, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 9 | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | 7 | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | 5 | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | 3 | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | 6 | Mar 15, 2024 |
| FY2020 | Jan 30, 2021 | 2 | Mar 15, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 15, 2021 |
| FY2020 | May 2, 2020 | (5) | Mar 15, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 15, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 9 | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | 7 | Mar 19, 2026 |
| FY2025 | Feb 3, 2024 | 5 | Mar 19, 2026 |
| FY2024 | Jan 28, 2023 | 3 | Mar 17, 2025 |
| FY2023 | Jan 29, 2022 | 6 | Mar 15, 2024 |
| FY2020 | Jan 30, 2021 | 2 | Mar 15, 2021 |
| FY2020 | Oct 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 15, 2021 |
| FY2020 | May 2, 2020 | (5) | Mar 15, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 15, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 62.72M | Mar 19, 2026 |
| FY2025 | Feb 1, 2025 | 63.28M | Mar 19, 2026 |
| FY2024 | Feb 3, 2024 | 63.96M | Mar 17, 2025 |
| FY2023 | Jan 28, 2023 | 65.02M | Mar 15, 2024 |
| FY2022 | Jan 29, 2022 | 66.49M | Mar 13, 2023 |
| FY2021 | Jan 30, 2021 | 66.39M | Mar 16, 2022 |
| FY2020 | Feb 1, 2020 | 65.93M | Mar 15, 2021 |
| FY2019 | Feb 2, 2019 | 67.15M | Mar 13, 2020 |
| FY2018 | Feb 3, 2018 | 67.87M | Mar 20, 2019 |
| FY2017 | Jan 28, 2017 | 70.18M | Mar 20, 2018 |